Labeling requirements could leave Russia 'without drugs,' says trade group

As well as some of the industry’s hottest topics internationally, a couple of issues of concern for drugmakers in Russia in particular were discussed at one of the country’s most significant pharma events last week.

The Russian Pharmaceutical Forum of the Adam Smith Institute was held in St Petersburg and brought leaders players in the sector together to discuss reference pricing, government procurement, drug insurance, innovation, relationships with pharmacy chains, digitalization of healthcare and patient centricity.

Disagreement over cryptocodes